Treatment horizons for triple-negative breast cancer
Publication in refereed journal


香港中文大学研究人员 ( 现职)

杨明明教授 (肿瘤学系)

全文

数位物件识别号 (DOI) http://dx.doi.org/10.12809/hkjr1515321

引用次数
Scopushttp://aims.cuhk.edu.hk/converis/portal/Publication/1Scopus source URL

其它资讯

摘要Triple-negative breast cancer is a distinct clinical subtype characterised by tumours that do not express oestrogen receptor, progesterone receptor, or HER-2 oncogene. Patients with triple-negative breast cancer have been reported to have a poor outcome. The mainstay of systemic treatment is chemotherapy. It has been noted that triple-negative breast cancer may be further sub-classified and one of the subclasses is the BRCA-associated tumour. In this article, systemic treatment for triple-negative breast cancer in the advanced metastatic, neoadjuvant, and adjuvant setting will be discussed. In particular, recent data in relation to the role of platinum compounds and poly (ADP-ribose) polymerase inhibitors will be reviewed.

着者Yeo W.
期刊名称Hong Kong Journal of Radiology
出版年份20http://aims.cuhk.edu.hk/converis/portal/Publication/15
月份http://aims.cuhk.edu.hk/converis/portal/Publication/1
日期http://aims.cuhk.edu.hk/converis/portal/Publication/1
卷号http://aims.cuhk.edu.hk/converis/portal/Publication/18
期次2
出版社Hong Kong Academy of Medicine Press
出版地China
页次http://aims.cuhk.edu.hk/converis/portal/Publication/1http://aims.cuhk.edu.hk/converis/portal/Publication/1http://aims.cuhk.edu.hk/converis/portal/Publication/1 - http://aims.cuhk.edu.hk/converis/portal/Publication/1http://aims.cuhk.edu.hk/converis/portal/Publication/18
国际标準期刊号2223-66http://aims.cuhk.edu.hk/converis/portal/Publication/19
电子国际标準期刊号2307-4620
语言英式英语

关键词Platinum, Poly(ADP-ribose) polymerases antagonists & inhibitors, Triple negative breast neoplasms